Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Feb;19(2):271–273. doi: 10.1128/aac.19.2.271

Susceptibility of shigellae to mecillinam, nalidixic acid, trimethoprim, and five other antimicrobial agents.

H B Hansson, M Walder, I Juhlin
PMCID: PMC181407  PMID: 6289727

Abstract

A total of 199 strains of shigella (1 Shigella dysenteriae, 15 S. boydii, 47 S. flexneri, and 136 S. sonnei) isolated in Malmö, Sweden, within a 3-year period (1977 through January 1980) were tested with the agar plate dilution method for susceptibility to commonly used and newer antimicrobial agents. Mecillinam, nalidixic acid, and trimethoprim had the best in vitro activity. S. flexneri dominated among strains resistant to three or more antimicrobial agents and were less susceptible to ampicillin, chloramphenicol, and doxycycline than other types studied. Sixty-four percent of the strains were resistant to sulfamethoxazole. In vitro, a synergistic effect with trimethoprim was shown only in strains susceptible to sulfamethoxazole. The amidinopenicillin mecillinam was highly active against shigellae. When resistance occurred, it was linked to ampicillin in 17 of 18 strains. The quinolines, here represented by nalidixic acid, might be the drugs of choice.

Full text

PDF
272

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burman L. G. Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria. J Antimicrob Chemother. 1977 Sep;3(5):509–516. doi: 10.1093/jac/3.5.509. [DOI] [PubMed] [Google Scholar]
  2. Byers P. A., Dupont H. L., Goldschmidt M. C. Antimicrobial susceptibilities of shigellae isolated in Houston, Texas, in 1974. Antimicrob Agents Chemother. 1976 Feb;9(2):288–291. doi: 10.1128/aac.9.2.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chang M. J., Dunkle L. M., Van Reken D., Anderson D., Wong M. L., Feigin R. D. Trimethoprim-sulfamethoxazole compared to ampicillin in the treatment of shigellosis. Pediatrics. 1977 May;59(5):726–729. [PubMed] [Google Scholar]
  4. Farrar W. E., Jr, Eidson M. Antibiotic resistance in Shigella mediated by R factors. J Infect Dis. 1971 May;123(5):477–484. doi: 10.1093/infdis/123.5.477. [DOI] [PubMed] [Google Scholar]
  5. Gordon R. C., Thompson T. R., Carlson W., Dyke J. W., Stevens L. I. Antimicrobial resistance of Shigellae isolated in Michigan. JAMA. 1975 Mar 17;231(11):1159–1161. [PubMed] [Google Scholar]
  6. JUHLIN I., ERICSON C. A new medium for the bacteriologic examination of stools (LSU-agar). Acta Pathol Microbiol Scand. 1961;52:185–200. doi: 10.1111/j.1699-0463.1961.tb03192.x. [DOI] [PubMed] [Google Scholar]
  7. Jarvis K. J., Scrimgeour G. In-vitro sensitivity of Shigella sonnei to trimethoprim and sulphamethoxazole. J Med Microbiol. 1970 Aug;3(3):554–557. doi: 10.1099/00222615-3-3-554. [DOI] [PubMed] [Google Scholar]
  8. Moorhead P. J., Parry H. E. Treatment of sonne dysentery. Br Med J. 1965 Oct 16;2(5467):913–915. doi: 10.1136/bmj.2.5467.913. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES